CagriSema

Synonyms: CagriSema, Cagrilintide/Semaglutide combination, Cagrilintide semaglutide, CagriSema peptide

As a research-grade peptide, CagriSema is offered primarily for investigational use in preclinical studies and formulation development. Its high purity and consistent quality make it suitable for in vitro and in vivo research aimed at understanding metabolic disorders and developing next-generation therapies.

Fonction

• Weight loss: Reduces appetite and increases satiety.
• Glycemic control: Improves insulin sensitivity and lowers blood glucose.
• Synergistic action: Combines amylin and GLP-1 receptor activation.

Source & Standardization

• Source: Synthetic peptide produced via solid-phase peptide synthesis.
• Pureté: ≥98% by HPLC.
• Formulaire: Lyophilized white powder.
• Applications: Research use only; not for human use

Demande de devis

• Notre adresse: 280, rue Main, Xi'an, Shaanxi, Chine
• LyvBio Co. — E-mail : info@lyvbio.com